About DalCor401
Application in support of clinical trials to determine safety of therapeutic intervention for use in humans. eDiary collects signs and symptoms of reactions for 28 days after the treatment and reports data to study investigators. Study participants will receive notification reminders to complete their daily eDiary in accordance with IRB approved schedule. Access to participate in this study requires informed consent by medical personnel. Only after consenting will participants receive an invitation to complete eDiaries. snapIoT and its platforms are HIPAA, California Privacy Rights Act, and GDPR compliant.
Similar Apps
Enhertu
Application in support of drug in clinical trials to determine safety for...
Imago CTP-203 (PV)
Reach out to clinician for access....
Konfident302
The Konfident302 clinical trial app is designed to enable participants to complete...
Sanofi VAS00006 HARMONIE
A Patient App for the Sanofi VAS00006 HARMONIE Study. This app is...
Vedanta VE202002
A clinical study app for subjects in the Vedanta VE202002 study.This app...
CRD-740-201 Site App
This app is created for doctors in the Cardurion CRD-740-201 Site only....